Robeco Institutional Asset Management B.V. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Robeco Institutional Asset Management B.V. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$557,487
+22.4%
20,4620.0%0.00%0.0%
Q2 2023$455,280
-32.8%
20,462
-34.5%
0.00%
-50.0%
Q1 2023$677,070
+6.6%
31,2590.0%0.00%0.0%
Q4 2022$634,870
+1.4%
31,259
+27.8%
0.00%0.0%
Q3 2022$626,000
-9.1%
24,450
-15.6%
0.00%0.0%
Q2 2022$689,000
+6.8%
28,962
+1.0%
0.00%0.0%
Q1 2022$645,000
+13.8%
28,6710.0%0.00%
+100.0%
Q4 2021$567,000
+0.5%
28,6710.0%0.00%0.0%
Q3 2021$564,000
-10.6%
28,6710.0%0.00%0.0%
Q2 2021$631,000
-32.3%
28,671
-26.8%
0.00%
-50.0%
Q1 2021$932,000
-28.4%
39,182
-21.3%
0.00%
-33.3%
Q4 2020$1,301,000
+32.6%
49,778
-11.6%
0.00%0.0%
Q3 2020$981,000
+33.3%
56,291
+28.7%
0.00%
+50.0%
Q2 2020$736,000
+41.5%
43,7530.0%0.00%0.0%
Q1 2020$520,000
+95.5%
43,753
+99.1%
0.00%
+100.0%
Q4 2019$266,000
-14.2%
21,9710.0%0.00%0.0%
Q3 2019$310,000
+6.9%
21,971
+24.7%
0.00%0.0%
Q1 2018$290,000
-8.8%
17,6240.0%0.00%
-50.0%
Q4 2017$318,000
-6.5%
17,6240.0%0.00%0.0%
Q3 2017$340,000
+63.5%
17,6240.0%0.00%
+100.0%
Q2 2017$208,00017,6240.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders